Market closedRefreshes 15sData NSENot investment advice
Viyash Scientific

Viyash Scientific

NSE: VIYASHBSE 512529sequent.in
View MapTV Chart
249.95
0.75+0.30%
DAY249
₹249.95
257
Open254.00
Prev Close249.20
Bid249.92951
Ask249.98594
Volume2.4M38%vs 20D avg
Market Cap₹10,916.9 Cr
Promoter Hold.61.4%
Face Value₹2
Fwd P/E
PEG
EV/EBITDA
P/S
ROA
Beta
Div Payout
Valuation

Viyash Scientific Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Viyash Scientific Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Viyash Scientific Ltd trades at a P/E of 206.00× and P/B of 6.34×.

Key MetricsLive · as of 12 Jun 2026
the price tag

Valuation

Market Cap
₹10,916.9 Cr
P/E Ratio
watch206
P/B Ratio
EPS
1.67
the engine

Profitability

ROE
watch3.21%
ROCE
watch8.47%
Net Margin
%
Op Margin
avg11.4%
the trajectory

Growth

EPS YoY
%
Revenue YoY
%
Qtr Sales
good15%
Qtr Profit
good504%
the balance sheet

Financial Health

Debt / Equity
good0.61
Book Value
32.2
Div Yield
%
Promoter Hold.
good61.4%
Financials

Viyash Scientific Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Viyash Scientific Ltd, switchable between annual and quarterly views, consolidated or standalone.

Viyash Scientific Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹10,916.9 Cr and reported EPS of ₹1.67.

Period201820192020202120222023202420252026
Revenue from Operations
849
1,039
1,179
1,362
1,413
1,421
1,370
1,551
3,420
Other Income
17
9
10
8
11
6
11
15
44
Total Income
866
1,048
1,189
1,370
1,424
1,427
1,381
1,566
3,464
Cost of Goods Sold (COGS)
462
543
605
695
793
834
760
812
1,563
Gross Profit
387
496
574
667
620
587
610
740
1,858
+Operating Expenses
304
371
404
455
510
575
549
578
1,205
EBITDA
83
125
170
212
109
12
61
162
653
+Non-Operating Expenses
73
75
86
66
67
26
92
122
259
Profit Before Tax (PBT)
24
59
94
137
53
-138
-55
44
349
+Tax Expense
13
2
12
32
8
-16
-25
12
124
Profit After Tax (PAT)
431
57
82
104
45
-122
-30
32
225
Earnings Per Share (EPS)
17.30
1.97
2.81
3.84
1.66
-4.86
-1.44
0.87
4.06
Diluted Shares Outstanding (Nos.)
25
25
25
25
25
25
25
25
44
+Additional Disclosures
1,595
1,487
1,681
1,993
2,058
2,307
2,119
2,317
4,788
Sales Growth %
22.35
13.46
15.47
3.76
0.57
-3.60
13.26
120.47
YoY Sales Growth %
22.35
13.46
15.47
3.76
0.57
-3.60
13.26
120.47
Material Cost %
41
44
43
43
47
49
45
40
40
Employee Cost %
13
14
14
14
16
18
18
18
17
Other Cost %
22
22
20
20
20
22
22
19
19
OPM %
10
12
14
16
8
1
4
10
19
Tax %
57
3
13
24
16
11
46
27
36
Profit Growth %
-86.80
44.25
27.31
-56.86
-370.70
75.72
208.94
596.37
Gross Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA Margin %
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratio
0.00
0.00
0.00
0.00
0.00
-0.00
-0.00
0.00
0.00
Additional Fields
42
83
120
161
58
-44
-0
95
419
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Viyash Scientific segment analysis: revenue and profit mix.

Disclosed business segments at Viyash Scientific with their share of revenue and profit, switchable between consolidated and standalone reporting.

Viyash Scientific discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Viyash Scientific Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Viyash Scientific Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

What can break it.

No weaknesses or threats on record.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 268. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.11. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

Shareholding

Viyash shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Viyash — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Viyash Scientific Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Viyash Scientific Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Sun Pharmaceutical Industries Ltd
₹4.34 Lakh Cr
Best Profit Growth
Biofil Chemicals & Pharmaceuticals Ltd
1318.00 %
Highest Dividend Yield
Sanofi India Ltd
7.63 %

Peer Comparison

Company Name
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Ltd
AARTIDRUGS
Aarti Drugs Ltd
AARTIPHARM
Aarti Pharmalabs Ltd
AJANTPHARM
Ajanta Pharma Ltd
AKUMS
Akums Drugs & Pharmaceuticals Ltd
ALBERTDAVD
Albert David Ltd
ALIVUS
Alivus Life Sciences Ltd
ALKEM
Alkem Laboratories Ltd
ALPA
Alpa Laboratories Ltd
AMRUTANJAN
Amrutanjan Health Care Ltd
APLLTD
Alembic Pharmaceuticals Ltd
ASTRAZEN
Astrazeneca Pharma India Ltd
AUROPHARMA
Aurobindo Pharma Ltd
BAFNAPH
Bafna Pharmaceuticals Ltd
BAJAJHCARE
Bajaj Healthcare Ltd
BALPHARMA
Bal Pharma Ltd
BIOCON
Biocon Ltd
BIOFILCHEM
Biofil Chemicals & Pharmaceuticals Ltd
BLISSGVS
Bliss GVS Pharma Ltd
BLUEJET
Blue Jet Healthcare Ltd
BROOKS
Brooks Laboratories Ltd
CAPLIPOINT
Caplin Point Laboratories Ltd
CIPLA
Cipla Ltd
COHANCE
Cohance Lifesciences Ltd
CONCORDBIO
Concord Biotech Ltd
DCAL
Dishman Carbogen Amcis Ltd
DIVISLAB
Divis Laboratories Ltd
DRREDDY
Dr Reddys Laboratories Ltd
EMCURE
Emcure Pharmaceuticals Ltd
ERIS
ERIS Lifesciences Ltd
FDC
FDC Ltd
GLAND
Gland Pharma Ltd
GLAXO
Glaxosmithkline Pharmaceuticals Ltd
GLENMARK
Glenmark Pharmaceuticals Ltd
GRANULES
Granules India Ltd
GUFICBIO
Gufic BioSciences Ltd
HALEOSLABS
Haleos Labs Limited
HESTERBIO
Hester Biosciences Ltd
HIKAL
Hikal Ltd
INDOCO
Indoco Remedies Ltd
INDSWFTLAB
Ind-Swift Laboratories Ltd
INNOVACAP
Innova Captab Ltd
IOLCP
IOL Chemicals & Pharmaceuticals Ltd
IPCALAB
Ipca Laboratories Ltd
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd
JBCHEPHARM
J B Chemicals & Pharmaceuticals Ltd
JUBLPHARMA
Jubilant Pharmova Ltd
KILITCH
Kilitch Drugs (India) Ltd
KOPRAN
Kopran Ltd
KREBSBIO
Krebs Biochemicals & Industries Ltd
LASA
Lasa Supergenerics Ltd
LAURUSLABS
Laurus Labs Ltd
LINCOLN
Lincoln Pharmaceuticals Ltd
LUPIN
Lupin Ltd
LYKALABS
Lyka Labs Ltd
MANGALAM
Mangalam Drugs and Organics Ltd
MANKIND
Mankind Pharma Ltd
MARKSANS
Marksans Pharma Ltd
MEDICAMEQ
Medicamen Biotech Ltd
MEDICO
Medico Remedies Ltd
MOREPENLAB
Morepen Laboratories Ltd
NATCOPHARM
Natco Pharma Ltd
NECLIFE
Nectar Lifescience Ltd
NEULANDLAB
Neuland Laboratories Ltd
NGLFINE
NGL Fine Chem Ltd
ONESOURCE
OneSource Specialty Pharma Ltd
ORCHPHARMA
Orchid Pharma Ltd
ORTINGLOBE
Ortin Global Ltd
PANACEABIO
Panacea Biotec Ltd
PFIZER
Pfizer Ltd
PGHL
Procter & Gamble Health Ltd
PPLPHARMA
Piramal Pharma Ltd
RPGLIFE
RPG Life Sciences Ltd
SAILIFE
Sai Life Sciences Ltd
SANOFI
Sanofi India Ltd
SANOFICONR
Sanofi Consumer Healthcare India Ltd
SENORES
Senores Pharmaceuticals Ltd
SHILPAMED
Shilpa Medicare Ltd
SIGACHI
Sigachi Industries Ltd
SMSPHARMA
SMS Pharmaceuticals Ltd
SOLARA
Solara Active Pharma Sciences Ltd
SPARC
Sun Pharma Advanced Research Company Ltd
STAR
Strides Pharma Science Ltd
SUNPHARMA
Sun Pharmaceutical Industries Ltd
SUPRIYA
Supriya Lifescience Ltd
SYNCOMF
Syncom Formulations (India) Ltd
THEMISMED
Themis Medicare Ltd
TORNTPHARM
Torrent Pharmaceuticals Ltd
UNICHEMLAB
Unichem Laboratories Ltd
VALIANTLAB
Valiant Laboratories Ltd
VENUSREM
Venus Remedies Ltd
VINEETLAB
Vineet Laboratories Ltd
VIYASH
Viyash Scientific LtdCurrent Stock
WANBURY
Wanbury Ltd
WINDLAS
Windlas Biotech Ltd
WOCKPHARMA
Wockhardt Ltd
ZIMLAB
Zim Laboratories Ltd
ZYDUSLIFE
Zydus Lifesciences Ltd
Technicals

Viyash Scientific Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Viyash Scientific Ltd — derived from the live tape, not yesterday's close.

Viyash Scientific Ltd last traded at ₹249.95 with an intraday range of ₹249.05–₹256.95 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹249.95
LevelPrice (₹)Distance% Δ
R4270.72+20.77+8.31%
R3262.82+12.87+5.15%
R2259.88+9.93+3.97%
R1254.92+4.97+1.99%
PIVOT251.982.030.81%
CURRENT249.95
S1231.22-18.73-7.49%
S2239.12-10.83-4.33%
S3244.08-5.87-2.35%
S4247.02-2.93-1.17%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 250.97P: 251.98TC: 253.00
R1
R2
R3
R4
indicator
LTP: 249.95
PDH: 255.40
PDL: 248.15
● Market Sentiment

VIYASH is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 252.35 ~ 256.95

● Price Position

Trading Inside opening range

Delivery & Volume

Viyash Scientific Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Viyash Scientific Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Viyash Scientific Ltd stood at 67.0% of traded volume, against a 20-day average of 49.3%.

Avg Delivery (20D)49.3%+17.7 ppt latest vs avg
Highest Delivery67%on 12 Jun
Avg Volume (20D)38.28 L20-day run-rate
Conviction Trend↑ Strengthening+17.7 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Viyash Scientific announcements: results, concalls, ratings, M&A.

Filings Viyash Scientific sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Viyash Scientific files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 37 documents below.

  1. 30 May 2026Copy of Newspaper PublicationView PDF

    Copy of Newspaper Publication

    Viyash Scientific Limited has informed the Exchange about Copy of Newspaper Publication

  2. 22 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Viyash Scientific Limited has informed the Exchange about Transcript

  3. 12 May 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Viyash Scientific Limited has informed the Exchange about Schedule of meet

  4. 30 Apr 2026Credit RatingView PDF

    Credit Rating

    Viyash Scientific Limited has informed the Exchange about Credit Rating

  5. 28 Apr 2026General UpdatesView PDF

    General Updates

    Viyash Scientific Limited has informed the Exchange about allotment of equity shares under the Company's ESOP Scheme.

Corporate Actions

Viyash Scientific dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Viyash Scientific has declared, sequenced by announce and record date.

Viyash Scientific corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Viyash Scientific Ltd: business, sector, key facts.

What Viyash Scientific Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Viyash Scientific Ltd is a listed Indian equity, listed as NSE: VIYASH, BSE: 512529.

VIYASH
Listed Equity

Viyash Scientific Ltd

NSE · VIYASH·BSE · 512529·sequent.in
company facts
Founded / IPO
Employees
Sector
Headquarters
Market Cap₹10,916.9 Cr
Listed OnNSE · BSE
leadership9 on record
Mr. Abhishek Singhal
Head of Investor Relations
Mr. Phillip Trott
Assoc. VP, Head of Legal & Chief Risk Officer
Mr. Prasad Lad
Vice President of HR & Administration
Mr. Rajaram Narayanan
MD, CEO & Director
Mr. Ramakant Singani
Chief Financial Officer
Mr. Ramesh Kumar Pillai
Corporate Vice President of Ra Qa and Technical Services
Mr. Ravi Nair
Executive Vice President of Human Resources & Administration
Mr. Srinivas Vasireddy
Executive Director
Ms. Yoshita Vora
Company Secretary & Compliance Officer
§ ∞ · Plainly Answered

Questions investors ask about Viyash Scientific Ltd (VIYASH).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Viyash Scientific Ltd (VIYASH)?

The current share price of Viyash Scientific Ltd (VIYASH) is ₹249.95. Today, the stock has gained by ₹0.75 (0.30%), trading in a range of ₹249.05 to ₹256.95. The stock opened at ₹254 with a trading volume of 23,76,512 shares.

02Is Viyash Scientific Ltd stock a good investment for long-term?

Viyash Scientific Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹10,916.9 crores, P/E ratio of 206.00, ROE of 3.21%, and ROCE of 8.47%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Viyash Scientific Ltd stock?

The 52-week high price of Viyash Scientific Ltd (VIYASH) is ₹0, while the 52-week low is ₹0. Currently trading at ₹249.95, the stock is Infinity% away from its 52-week low and -Infinity% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Viyash Scientific Ltd stock at the current price?

Whether to buy Viyash Scientific Ltd stock at ₹249.95 depends on multiple factors. The stock is currently trading with a P/E ratio of 206.00 and P/B ratio of 6.34. Today's performance shows a gain of 0.30%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Viyash Scientific Ltd and when is the next dividend?

Viyash Scientific Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹249.95, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Viyash Scientific Ltd?

Viyash Scientific Ltd's key financial metrics include: P/E Ratio: 206.00, P/B Ratio: 6.34, ROE: 3.21%, ROCE: 8.47%, Dividend Yield: 0.00%, EPS: ₹1.67, Book Value: ₹32.2, and Debt-to-Equity: 0.61. The company's market cap stands at ₹10,916.9 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Viyash Scientific Ltd stock performing today in the market?

Viyash Scientific Ltd stock opened at ₹254 and is currently trading at ₹249.95, showing a gain of ₹0.75 (0.30%). The intraday high is ₹256.95 and low is ₹249.05. The trading volume stands at 23,76,512 shares, indicating strong market participation today.

08What is the P/E ratio of Viyash Scientific Ltd and what does it indicate?

Viyash Scientific Ltd has a Price-to-Earnings (P/E) ratio of 206.00, which means investors are willing to pay ₹206.00 for every ₹1 of earnings. With an EPS of ₹1.67, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Viyash Scientific Ltd (VIYASH) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.